DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on August 25, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

New Tool to Report Health Care Provider Complaints
July 19, 2016

The Complaint Portal is a way for consumers to find the correct agency to submit health care complaints in an electronic and secure format. Continue reading


FREE Webinars Now Available
July 19, 2016

Learn how to add your license to your Online Services Portal account or report your continuing education/continuing medical education (CE/CME) requirements. Continue reading